DB
Therapeutic Areas
Dermapharm Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Biosimilar Portfolio | Immunology / Oncology (various) | Development / Registration |
| Complex Generic Formulations | Dermatology, Pain, Other | Bioequivalence / Registration |
| Allergopharma Immunotherapy | Allergic Rhinitis, Asthma | Marketed / Lifecycle Management |
Leadership Team at Dermapharm
DH
Dr. Hans-Georg Feldmeier, PhD
Chairman of the Management Board (CEO)
DJ
Dr. Jürgen Groß, PhD
Member of the Management Board (CFO)
DS
Dr. Stefan Schiemann, PhD
Member of the Management Board (CSO)
DU
Dr. Ulrich Köstlin
Chairman of the Supervisory Board